DYADIC INTERNATIONAL INC Cash and Restricted Cash
DYADIC INTERNATIONAL INC (DYAI) had Cash and Restricted Cash of $2.98 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.98M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.16M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.85M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.16M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $2.98M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $5.16M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $5.85M 10-K · filed 2026-03-25 |
| 2025-09-30 | $7.16M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.97M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $5.06M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $6.51M 10-K · filed 2026-03-25 |
| 2024-09-30 | $5.92M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $6.13M 10-Q · filed 2025-08-13 |
| 2020-12-31 | $20.64M 10-K · filed 2021-03-30 |
| 2020-09-30 | $21.86M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $11.78M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $4.70M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $4.82M 10-K · filed 2021-03-30 |
| 2019-09-30 | $4.66M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $4.78M 10-Q · filed 2020-08-13 |
| 2019-03-31 | $3.98M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $2.39M 10-K · filed 2021-03-30 |
| 2018-09-30 | $1.71M 10-Q · filed 2019-11-13 |
| 2018-06-30 | $3.22M 10-Q · filed 2019-08-13 |
| 2018-03-31 | $4.63M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $5.79M 10-K · filed 2020-03-30 |
| 2016-12-31 | $14.25M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |